Article Text

other Versions

PDF
Images in thorax
Pulmonary endarterectomy for calcified amorphous tumour-related pulmonary hypertension
  1. Peter I Bonta1,
  2. Harm J Bogaard2,
  3. Inge van den Berk3,
  4. Hans W M Niessen4,
  5. Allard van der Wal5,
  6. Petr Symersky4
  1. 1Department of Pulmonary Medicine, University of Amsterdam, Academic Medical Center (AMC), Amsterdam, The Netherlands
  2. 2Department of Pulmonary Medicine, Free University Medical Center (VUMC), Amsterdam, The Netherlands
  3. 3Department of Radiology, University of Amsterdam, Academic Medical Center (AMC), Amsterdam, The Netherlands
  4. 4Department of Pathology and Cardiac Surgery, Free University Medical Center (VUMC), ICaR-VU, Amsterdam, The Netherlands
  5. 5Department of Pathology, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
  1. Correspondence to Dr Peter I Bonta, Department of Pulmonary Medicine, University of Amsterdam, Academic Medical Center (AMC), Meibergdreef 9, Amsterdam 1105AZ, The Netherlands; p.i.bonta{at}amc.nl

Statistics from Altmetric.com

A 42-year-old patient presenting with exertional dyspnoea was diagnosed with functional class II pulmonary hypertension (PH) with severe tricuspid valve insufficiency due to cardiac and pulmonary artery obstruction by calcified amorphous tumour (paCAT). Bilateral (sub)segmental perfusion defects were seen on ventilation/perfusion scan (see online supplementary figure S1), while the CT angiogram showed large amounts of calcified radio-opaque material in absence of radiological characteristics of chronic thromboembolic pulmonary hypertension (CTEPH), such as webs, stenosis or pouches (figure 1A, C). After multi-institutional (Amsterdam, NL and Papworth, Cambridge, UK) assessment of the case, a decision was made to perform a complete, bilateral, pulmonary endarterectomy (PEA) combined with tricuspid valve replacement. During PEA bone-hard material was retrieved that lacked the (sub)segmental pulmonary …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.